Navigation Links
Mathew to Lead PPD Drug Development Operations and Expansion in India
Date:12/12/2007

Company announces second office in Mumbai

WILMINGTON, N.C., Dec. 12 /PRNewswire-FirstCall/ -- PPD, Inc. (Nasdaq: PPDI) today announced the appointment of Philip Mathew, M.D., as director of strategic development, to lead the company's Phase II-IV operations and expansion in India.

Dr. Mathew will provide strategic leadership for PPD's drug development business on the Indian subcontinent, including clinical project management and patient recruitment for key therapeutic areas. He will also be responsible for identifying and helping to develop new clinical sites and business opportunities as well as liaising with local and national government departments.

"A native of India, Dr. Mathew brings extensive clinical trials experience and in-depth knowledge of the healthcare industry in this country," said Simon Britton, vice president of clinical operations for PPD in Asia. "His leadership will enable us to strengthen our presence in this important global clinical research market as we continue to meet the growing needs of our clients. We are pleased to welcome him to PPD."

The company also announced it is opening a second Mumbai office, where Dr. Mathew will be based. The office, located at the Dynasty facility in the Mumbai business district, expands the company's global footprint for providing clinical services.

Prior to joining PPD, Dr. Mathew was associate medical director at Covance Inc. He had previously served as principal investigator with MDS Pharma Services; attending physician with the Robert Wood Johnson University Hospital; instructor of medicine with the University of Medicine and Dentistry of New Jersey; staff physician with the Clinical Research Center of the Robert Wood Johnson Medical School and University of Medicine and Dentistry of New Jersey; and consultant physician with the Church of South India Mission Hospital.

Dr. Mathew attended St. Joseph's College at Calicut University in Kerala, In
'/>"/>

SOURCE PPD, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
3. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
4. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
5. Global Experts Explore Entire Spectrum of Aids Vaccine Development
6. Vical Names Andrew de Guttadauro Vice President, Corporate Development
7. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
8. SemBioSys updates Apo AI development program
9. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... today announced it has initiated commissioning activities for its ... Sarnia, Ontario , Canada.  ... months, with the facility being in commercial operation in ... in two months and it is carrying out commissioning ...
(Date:3/3/2015)... 03, 2015 GlobalStemCellsGroup.com has ... Camacho Alcocer, a biomedical researcher and founding partner of ... GSCG’s team of biomedical professors who will teach the ... Criogenix SA de CV is a private company registered ... and Companies in Mexico (RENIECYT). , Camacho Alcocer will ...
(Date:3/2/2015)... MD and Fort Washington, PA (PRWEB) March 02, 2015 ... Genetics (ASHG) and ReachMD announced today ... of audio interviews designed to educate healthcare professionals on ... management. , The series features peer-to-peer interviews ... topics such as:, ,     Translational Genomics and ...
(Date:3/2/2015)... In the five years to 2015, the ... growth. The industry, which consists of companies that perform ... other goods, has grown on account of an improving ... IBISWorld forecasts that industry revenue will increase at an ... the five-year period, including an anticipated increase of 2.8% ...
Breaking Biology Technology:BioAmber Begins Commissioning of Sarnia Commercial Plant 2BioAmber Begins Commissioning of Sarnia Commercial Plant 3Mario Camacho Alcocer Joins Global Stem Cells Group Faculty 2Mario Camacho Alcocer Joins Global Stem Cells Group Faculty 3American Society of Human Genetics (ASHG) and ReachMD Launch Series on Genetics and Genomics 2American Society of Human Genetics (ASHG) and ReachMD Launch Series on Genetics and Genomics 3Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 2Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 3
... leader in room,temperature biological sample stabilization, announced today that ... Sales and Marketing.,Biomatrica,s interim Vice President of Sales and ... company and will continue to serve as,an advisor on ... years of sales and marketing experience in,the biotech industry. ...
... of 98% in net earnings from continuing operations during the first ... 2008 to reach 10.5 million US dollars ... All amounts in US dollars, QUEBEC ... developer, manufacturer and marketer of,added value products for health and nutrition industries, ...
... NeoGenomics, Inc. (OTC,Bulletin Board: NGNM) announced today that it ... May 7, 2008., The Company has scheduled a ... May 7, 2008, at 11:00 AM EDT. Interested investors ... minutes prior to the call. A replay of the ...
Cached Biology Technology:Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing 2Atrium shows a strong financial performance for its first quarter 2Atrium shows a strong financial performance for its first quarter 3Atrium shows a strong financial performance for its first quarter 4Atrium shows a strong financial performance for its first quarter 5NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008 2
(Date:2/5/2015)... January 28, 2015 New Market ... And Segment Forecasts To 2020 has Been Added to ... market is expected to reach USD 5.10 billion by ... Research, Inc. IR cameras help identify the site of ... to witness surging demand in medical imaging applications. They ...
(Date:1/22/2015)... Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the addition ... report to their offering. , The primary ... is who she/he is claiming to be, and for this ... physical characteristics, such as fingerprint, hand or palm print, iris, ...
(Date:1/22/2015)... MADISON, Wis. , Jan. 15, 2015  BellBrook ... for drug discovery, announced the launch of a ... of the company,s Transcreener UDP Assay, a high ... enzymes. The new assay will allow for sensitive ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... has been the inspiration for countless books and movies, ... engineers. Researchers at the California Institute of Technology (Caltech) ... intelligencenot in a robot or a silicon chip, but ... to have made an artificial neural network out of ...
... Mobile devices have become as common as the stethoscope in ... read test results, access diagnostic tools and take patient notes, ... smartphone or using a flash drive. These mobile devices are ... huge security risks to patient information. In less ...
... LOS ALAMOS, New Mexico, July 20, 2011Researchers at the ... Great Lakes Bioenergy Research Center have found a potential ... materials such as corn leaves and stalks, or switch ... Journal of the American Chemical Society , Los Alamos ...
Cached Biology News:Caltech researchers create the first artificial neural network out of DNA 2Caltech researchers create the first artificial neural network out of DNA 3Caltech researchers create the first artificial neural network out of DNA 4Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 2Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 3Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 4Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth 5Researchers find potential key for unlocking biomass energy 2
Co-precipitant is free of background polynucleotides,Dnases,Rnases, proteases. 20mg/ml...
Can be used for the quantitative recovery of small amounts of nucleic acids within dilute solutions. 5mg/ml...
RAB32, member RAS oncogene family, mRNA (cDNA clone MGC:13500 IMAGE:4280407), complete cds...
Can be used for the quantitative recovery of small amounts of nucleic acids within dilute solutions. 5mg/ml...
Biology Products: